Medicine Stock Based on AI: Returns up to 89.20% in 3 Months

Medicine Stock

The Medicine Stocks Package is designed for investors and analysts who need predictions for the best stocks to buy in the Medicine Industry. It includes 20 stocks with bullish and bearish signals and indicates the best medicine stocks to trade:

  • Top 10 Medicine stocks for the long position
  • Top 10 Medicine stocks for the short position

Package Name: Medicine Stocks
Recommended Positions: Long & Short
Forecast Length: 3 Months (02/17/2017 – 05/17/2017)
I Know First Average: 17.88% (Long) & 8.10% (Short)
Medicine Stock

During the 3 Months forecast, the algorithm had predicted high returns for those seeking stock advice. The best performance in the short position came from BVX which registered a return of 38.62%. For the long positions the largest growth was registered by IMGN with a return of 89.20%, during the same period. The package itself, had an overall average return of 17.88%, in the long position, providing a premium of 17.46% over the SP500’s return of 0.42%. With regards to the short position, the package had an overall average return of 8.10%, providing investors with a premium of 7.68% over S&P500’s return of 0.42%. The I Know First’s Stock Market Algorithm accurately forecasted 6 out of 10 stocks, for the long position, and 6 out of 10 stocks, for the short position for this 3 Months forecasted period.

ImmunoGen, Inc. (IMGN), a biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugate (ADC) technology.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.